Canada finds no BPA risks in formula
This article was originally published in The Tan Sheet
A Canadian survey of bisphenol A in canned powdered infant formulas determines the chemical used in the internal coating of food containers "is not expected to pose a health risk to the general population, including newborns and infants." Health Canada analyzed 38 formula products -- including Similac and Isomil from Abbott Labs, Enfamil from Mead Johnson and Good Start from Nestle -- and found BPA concentration below the average method detection limit of 0.13 nanograms per gram in all samples, according to a July report. One ng/g is equivalent to 1 part per billion. The report says FDA agrees with the Canadian agency's health risk conclusions, though Congress wants FDA to reassess BPA risks as part of pending food safety legislation (1"The Tan Sheet" June 22, 2009)
You may also be interested in...
The House Energy and Commerce Committee added a requirement that FDA reassess bisphenol A risks before approving a food safety reform bill
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.